FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4319984881> ?p ?o ?g. }

• W4319984881 abstract "Introduction Obstructive Airway Diseases (OADs) are the leading cause of death among chronic respiratory diseases worldwide, and novel therapies are direly needed. Fluticasone furoate/vilanterol (FF/Vi) (100/25 µg) is the first once-daily ICS/uLABA marketed in India for COPD since 2021. Considering its limited real-world experience in OAD patients in Indian clinical settings, a large drug utilization study (DUS) was planned. Methodology We conducted a cross-sectional, observational DUS at 1900 outpatient clinics in India from October 2021 to March 2022. Prescription data and medical history of patients who were prescribed the FF/Vi combination were collected. Results It was observed that FF/Vi was prescribed in an almost equal number of patients with COPD (44.2%) and asthma (42.9%). The majority of the patients (74%) were switched from previous ICS/LABA to this ICS/uLABA, while 26% of patients were treatment naïve. The average CAT score was 19.5±7.8 (43.2% GOLD Group C and 32.2% GOLD Group B) in COPD patients, while the average ACQ-5 score was 2.6±1.3 (33.1% GINA Step 3, 29.5% GINA Step 2) in asthmatic patients. Most of the patients (63.9%) had raised biomarkers (Blood eosinophil count >300 cells/μl). Prior history of exacerbation was present in 65% of patients with annual exacerbation rates of 1.2 in COPD, 1.1 in asthma, and 1.2 in asthma-COPD overlap syndrome (ACOS). Leukotriene inhibitors (42%) and LAMAs (30.8%) were common add-on medications. Conclusion We observed a trend towards a shift to once-daily ICS/uLABA (FF/Vi) by physicians, especially in symptomatic and exacerbating OAD patients with underlying comorbidities." @default.
• W4319984881 created "2023-02-11" @default.
• W4319984881 creator A5007823997 @default.
• W4319984881 creator A5008307486 @default.
• W4319984881 creator A5014429277 @default.
• W4319984881 creator A5040556984 @default.
• W4319984881 creator A5049508277 @default.
• W4319984881 creator A5070489582 @default.
• W4319984881 creator A5075467464 @default.
• W4319984881 creator A5079746705 @default.
• W4319984881 creator A5080910293 @default.
• W4319984881 date "2023-02-09" @default.
• W4319984881 modified "2023-10-03" @default.
• W4319984881 title "Fluticasone Furoate/Vilanterol Use Trends and Characteristics in Patients With Obstructive Airway Disease: A Real-World Study of 10,374 Patients From India" @default.
• W4319984881 cites W1861036421 @default.
• W4319984881 cites W1881393816 @default.
• W4319984881 cites W1987881697 @default.
• W4319984881 cites W2049979738 @default.
• W4319984881 cites W2082605777 @default.
• W4319984881 cites W2130795051 @default.
• W4319984881 cites W2143096094 @default.
• W4319984881 cites W2195730285 @default.
• W4319984881 cites W2327645667 @default.
• W4319984881 cites W2345686813 @default.
• W4319984881 cites W2511149840 @default.
• W4319984881 cites W2512624858 @default.
• W4319984881 cites W2740353415 @default.
• W4319984881 cites W2753577203 @default.
• W4319984881 cites W2772741062 @default.
• W4319984881 cites W2802221596 @default.
• W4319984881 cites W2809691396 @default.
• W4319984881 cites W2889479419 @default.
• W4319984881 cites W2889606340 @default.
• W4319984881 cites W2895420512 @default.
• W4319984881 cites W2901307026 @default.
• W4319984881 cites W2982153371 @default.
• W4319984881 cites W2999425512 @default.
• W4319984881 cites W3002275213 @default.
• W4319984881 cites W3002844542 @default.
• W4319984881 cites W3018267933 @default.
• W4319984881 cites W3025904018 @default.
• W4319984881 cites W3033438356 @default.
• W4319984881 cites W3084377968 @default.
• W4319984881 cites W3143595100 @default.
• W4319984881 cites W4205350391 @default.
• W4319984881 cites W4210819634 @default.
• W4319984881 doi "https://doi.org/10.7759/cureus.34825" @default.
• W4319984881 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/36919064" @default.
• W4319984881 hasPublicationYear "2023" @default.
• W4319984881 type Work @default.
• W4319984881 citedByCount "0" @default.
• W4319984881 crossrefType "journal-article" @default.
• W4319984881 hasAuthorship W4319984881A5007823997 @default.
• W4319984881 hasAuthorship W4319984881A5008307486 @default.
• W4319984881 hasAuthorship W4319984881A5014429277 @default.
• W4319984881 hasAuthorship W4319984881A5040556984 @default.
• W4319984881 hasAuthorship W4319984881A5049508277 @default.
• W4319984881 hasAuthorship W4319984881A5070489582 @default.
• W4319984881 hasAuthorship W4319984881A5075467464 @default.
• W4319984881 hasAuthorship W4319984881A5079746705 @default.
• W4319984881 hasAuthorship W4319984881A5080910293 @default.
• W4319984881 hasBestOaLocation W43199848811 @default.
• W4319984881 hasConcept C126322002 @default.
• W4319984881 hasConcept C2426938 @default.
• W4319984881 hasConcept C2775941666 @default.
• W4319984881 hasConcept C2776042228 @default.
• W4319984881 hasConcept C2776780178 @default.
• W4319984881 hasConcept C2776804153 @default.
• W4319984881 hasConcept C2777014857 @default.
• W4319984881 hasConcept C2779028295 @default.
• W4319984881 hasConcept C2781212218 @default.
• W4319984881 hasConcept C2781348165 @default.
• W4319984881 hasConcept C3020110884 @default.
• W4319984881 hasConcept C71924100 @default.
• W4319984881 hasConcept C98274493 @default.
• W4319984881 hasConceptScore W4319984881C126322002 @default.
• W4319984881 hasConceptScore W4319984881C2426938 @default.
• W4319984881 hasConceptScore W4319984881C2775941666 @default.
• W4319984881 hasConceptScore W4319984881C2776042228 @default.
• W4319984881 hasConceptScore W4319984881C2776780178 @default.
• W4319984881 hasConceptScore W4319984881C2776804153 @default.
• W4319984881 hasConceptScore W4319984881C2777014857 @default.
• W4319984881 hasConceptScore W4319984881C2779028295 @default.
• W4319984881 hasConceptScore W4319984881C2781212218 @default.
• W4319984881 hasConceptScore W4319984881C2781348165 @default.
• W4319984881 hasConceptScore W4319984881C3020110884 @default.
• W4319984881 hasConceptScore W4319984881C71924100 @default.
• W4319984881 hasConceptScore W4319984881C98274493 @default.
• W4319984881 hasLocation W43199848811 @default.
• W4319984881 hasLocation W43199848812 @default.
• W4319984881 hasLocation W43199848813 @default.
• W4319984881 hasOpenAccess W4319984881 @default.
• W4319984881 hasPrimaryLocation W43199848811 @default.
• W4319984881 hasRelatedWork W1969372887 @default.
• W4319984881 hasRelatedWork W2048185200 @default.
• W4319984881 hasRelatedWork W2100738224 @default.
• W4319984881 hasRelatedWork W2195424142 @default.
• W4319984881 hasRelatedWork W2354927821 @default.
• W4319984881 hasRelatedWork W2886053977 @default.
• W4319984881 hasRelatedWork W3028919337 @default.

• next